iNOS expression and lethal prostate cancer in patients with localized disease

被引：0
|
作者：
Rider, Jennifer R. [1 ]
Erlandsson, Ann [2 ]
Vyas, Chirag [1 ]
Davidsson, Sabina [2 ]
Carlsson, Jessica [2 ]
Andersson, Swen-Olof [2 ]
Andren, Ove [2 ]
机构：
[1] Boston Univ, Sch Publ Hlth, Boston, MA USA
[2] Orebro Univ Hosp, Orebro, Sweden
来源：
CANCER RESEARCH | 2017年 / 77卷 / 22期
关键词：
D O I：
10.1158/1538-7445.NEWFRONT17-B26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B26
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease
    Lu, Donghao
    Carlsson, Jessica
    Penney, Kathryn L.
    Davidsson, Sabina
    Andersson, Swen-Olof
    Mucci, Lorelei A.
    Valdimarsdottir, Unnur
    Andren, Ove
    Fang, Fang
    Fall, Katja
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (12) : 1781 - 1787
  • [2] Prostate cancer: The localized disease
    Avances, Christophe
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (01): : 46 - 50
  • [3] Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer
    Rubicz, Rohina
    Zhao, Shanshan
    Wright, Jonathan L.
    Coleman, Ilsa
    Grasso, Catherine
    Geybels, Milan S.
    Leonardson, Amy
    Kolb, Suzanne
    April, Craig
    Bibikova, Marina
    Troyer, Dean
    Lance, Raymond
    Lin, Daniel W.
    Ostrander, Elaine A.
    Nelson, Peter S.
    Fan, Jian-Bing
    Feng, Ziding
    Stanford, Janet L.
    MOLECULAR ONCOLOGY, 2017, 11 (02) : 140 - 150
  • [4] Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease
    Ahearn, Thomas U.
    Peisch, Sam
    Pettersson, Andreas
    Ebot, Ericka M.
    Zhou, Cindy Ke
    Graff, Rebecca E.
    Sinnott, Jennifer A.
    Fazli, Ladan
    Judson, Gregory L.
    Bismar, Tarek A.
    Rider, Jennifer R.
    Gerke, Travis
    Chan, June M.
    Fiorentino, Michelangelo
    Flavin, Richard
    Sesso, Howard D.
    Finn, Stephen
    Giovannucci, Edward L.
    Gleave, Martin
    Loda, Massimo
    Li, Zhe
    Pollak, Michael
    Mucci, Lorelei A.
    CARCINOGENESIS, 2018, 39 (12) : 1431 - 1437
  • [5] DIFFERENTIAL EXPRESSION OF RANKL AND OSTEOPROTEGERIN IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER
    Todenhoefer, Tilman
    Hennenlotter, Joerg
    Hohneder, Andrea
    Kuehs, Ursula
    Schilling, David
    Aufderklamm, Stefan
    Alloussi, Saladin
    Gakis, Georgios
    Stenzl, Arnulf
    Schwentner, Christian
    JOURNAL OF UROLOGY, 2011, 185 (04): : E53 - E53
  • [6] PROSTATE CANCER The genomics of localized disease
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2017, 14 (02) : 65 - 65
  • [7] A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer
    Juracek, Jaroslav
    Madrzyk, Marie
    Stanik, Michal
    Ruckova, Michaela
    Trachtova, Karolina
    Malcikova, Hana
    Lzicarova, Eva
    Barth, Dominik A.
    Pichler, Martin
    Slaby, Ondrej
    PROSTATE, 2023, 83 (04): : 340 - 351
  • [8] THE RISK OF DYING OF PROSTATE-CANCER IN PATIENTS WITH CLINICALLY LOCALIZED DISEASE
    LERNER, SP
    SEALEHAWKINS, C
    CARLTON, CE
    SCARDINO, PT
    JOURNAL OF UROLOGY, 1991, 146 (04): : 1040 - 1045
  • [9] WGC in patients with localized prostate cancer
    Masone, Maria Chiara
    NATURE REVIEWS UROLOGY, 2022, 19 (12) : 694 - 694
  • [10] WGC in patients with localized prostate cancer
    Maria Chiara Masone
    Nature Reviews Urology, 2022, 19 : 694 - 694
12345